http://www.pharmaceutical-technology.com/news/fda-draft-guidance/
0
0
31 words
0
Comments
The US FDA has issued a draft guidance to aid sponsors in developing biologics and drugs for stimulant use disorders.
You are the first to view
Create an account or login to join the discussion